Format

Send to

Choose Destination
J Infect Dis. 2018 Jun 20;218(2):228-233. doi: 10.1093/infdis/jiy001.

Abacavir Induces Arterial Thrombosis in a Murine Model.

Author information

1
Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.
2
FISABIO-Fundación Hospital Universitario Dr Peset, Valencia, Spain.
3
CIBERehd, Valencia, Spain.

Abstract

Background:

The purinergic system is known to underlie prothrombotic and proinflammatory vascular programs, making the profile of experimental actions demonstrated by abacavir compatible with thrombogenesis. However, direct evidence of a prothrombotic effect by the drug has been lacking.

Methods:

The present study appraised the effects of abacavir in a well-validated animal model of arterial thrombosis. The role of ATP-P2X7 receptors in the actions of the drug was also assessed, and the actions of recognized vascular-damaging agents and other nucleoside reverse-transcriptase inhibitors (NRTIs) were evaluated and compared to those of abacavir.

Results:

Abacavir dose-dependently promoted thrombus formation. This effect was reversed by a P2X7-receptor antagonist and was nonexistent in P2X7 knockout mice. The effects of abacavir were similar to those of diclofenac and rofecoxib. Other NRTIs had no thrombosis-related effects.

Conclusion:

Abacavir promotes arterial thrombosis through interference with purinergic signaling, suggesting a possible biological mechanism for the clinical association of abacavir with cardiovascular diseases.

PMID:
29346575
DOI:
10.1093/infdis/jiy001

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center